BlockBeats News, August 1st, according to official sources, AI Agent platform ChainOpera AI has partnered with the re-staking protocol EigenLayer to jointly promote the construction of "Runtime-Verifiable AI Agent" infrastructure. The two parties will achieve end-to-end verification of AI Agent reasoning and execution behavior through on-chain auditing mechanisms, promoting the evolution of AI services from a "black box" to "trusted collaboration."
Currently, ChainOpera has built a community-driven AI Agent social network that supports collaborative completion of tasks such as transactions, predictions, and productivity with personalized virtual friends. The platform's daily interaction volume has exceeded 600,000 times, with over 300,000 cumulative paid users.
Users can interact with multiple Agents and participate in the Prompt-to-Earn incentive mechanism at chat.chainopera.ai; developers can build and publish Agents at agent.chainopera.ai to earn points and token revenue based on quality and usage.
It is reported that the CEO of ChainOpera and EigenLayer both come from the laboratory of Professor David Tse at Stanford/Berkeley and have conducted joint research at Berkeley. This cooperation continues the past collaboration and is seen as a deep collaboration between the two major infrastructure forces in the trusted on-chain AI direction, which is highly anticipated.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.












Latest Crypto Market Snapshot as of August 22, 2025 BTC Soars to $115,250.00 ETH Hits $4,450.75 XRP Climbs…

I’ve been diving into cryptocurrency airdrops for years, and I can tell you from personal experience that the…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.
